
By Roni Caryn Rabin from NYT Health https://ift.tt/3x4gmaO


Study data shows the drug may slow Alzheimer’s progression by 27% over 18 months.

Karen D. Lincoln, PhD, a professor who has studied aging Black Americans, discusses the needs of this population as it faces chronic conditions, loneliness, a lack of access to services, and other physical and mental health concerns.